GENE ONLINE|News &
Opinion
Blog

First Nasal Spray for Allergies Now Available Over-the-Counter

by Fujie Tham
Share To

Bayer shared that its Astepro (azelastine) antihistamine nasal spray is now available over-the-counter (OTC) in the US, making it the first and only allergy spray to be marketed under these settings. 

Astepro is made up of 0.15% the prescription-strength antihistamine, azelastine and takes only 30 minutes to work, the spray is indicated to relieve congestion and symptoms of seasonal and perennial allergic rhinitis, also known as allergies, for 6 years old and above. The spray was approved by the FDA for nonprescription use in June 2021, after a process called a partial prescription to nonprescription switch.

“Allergy sufferers now have access to the fastest, 24-hour nasal allergy medicine available OTC with steroid-free Astepro Allergy – a breakthrough in the category. With the sheer speed of our product, allergy sufferers can embrace the moment without worrying about when they will feel relief,” said Catherine Vennat, Vice President/General Manager of Upper Respiratory, Bayer US Consumer Health.

Related article: NIH Launches mRNA Nipah Virus Vaccine Trial With Moderna

 

50M Allergies Sufferers Annually Means Big Market Potential

 

Following the pandemic, Bayer is actively diversifying its allergy unit’s portfolio after a drop in sales during the pandemic, with sales dropping 34.9% in the first quarter of 2021. The company cited the increase in hygiene measures and lockdowns as the cause of this drop.

While Astepro was planned to hit American shelves during this year’s spring season, the product may have missed 2022’s peak allergy season, but there are still demands for the product as waves of allergens tend to fluctuate throughout the year in the US. Tree pollination begins earliest in the year followed by grass pollination later in the spring and summer, then followed by ragweed in late summer and fall.

According to the American College of Allergy, Asthma & Immunology, allergies are one of the top leading causes of chronic illness in the United States, and more than 50 million Americans suffer from allergies each year.

The nasal spray’s OTC availability allows people with allergies to have an effective and easy antihistamine option without needing assistance from a healthcare provider.

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Bayer Signs Up To Google Cloud To Boost Drug Discovery
2023-01-13
JPM23: Development and Strategic Updates from JP Morgan Healthcare Conference 2023 Day Two
2023-01-10
Retail Pharmacies Can Dispense Abortion Pills Under New FDA Ruling
2023-01-05
LATEST
Junshi’s PD-1 Antibody Meets Endpoint In Phase 3 Lung Cancer Trial
2023-01-19
Moderna Welcomes Phase 3 Win For RSV Vaccine
2023-01-18
Moving Beyond COVID With mRNA Technology
2023-01-18
Rob Knight and Jing-Yuan Fu Elaborate On Microbiome Research Trends at the 7th Asia Microbiome Conference(AMC)
2023-01-17
CARsgen Taps Huadong to Commercialize Multiple Myeloma CAR-T in China
2023-01-17
Scientists Study Imaging Probes in First-Ever Amputated Human Limb Model
2023-01-16
EMA Plans to Issue Liver Failure Warning for Novartis’ Gene Therapy
2023-01-16
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!